ENTRY       D07875                      Drug
NAME        Doxepin (INN);
            Sinequan (TN)
FORMULA     C19H21NO
EXACT_MASS  279.1623
MOL_WEIGHT  279.3761
CLASS       Neuropsychiatric agent
             DG01730  Non-selective monoamine reuptake inhibitor
             DG01728  Tricyclic antidepressant
            Metabolizing enzyme substrate
             DG01892  CYP1A2 substrate
             DG01642  CYP2C9 substrate
             DG01639  CYP2C19 substrate
             DG01644  CYP2D6 substrate
REMARK      Same as: C06971
            ATC code: D04AX01 N06AA12
            Chemical structure group: DG00937
            Product (DG00937): D00814<US>
EFFICACY    Antidepressant, H1 receptor antagonist, Serotonin-noradrenaline reuptake inhibitor (SNRI)
TARGET      HRH1 [HSA:3269] [KO:K04149]
            SLC6A4 (HTT) [HSA:6532] [KO:K05037]
            SLC6A2 (NAT1) [HSA:6530] [KO:K05035]
  PATHWAY   hsa04080(3269)  Neuroactive ligand-receptor interaction
            hsa04721(6530+6532)  Synaptic vesicle cycle
            hsa04726(6532)  Serotonergic synapse
            hsa04750(3269)  Inflammatory mediator regulation of TRP channels
METABOLISM  Enzyme: CYP2C19 [HSA:1557], CYP2D6 [HSA:1565]; CYP1A2 [HSA:1544], CYP2C9 [HSA:1559]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             D DERMATOLOGICALS
              D04 ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
               D04A ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
                D04AX Other antipruritics
                 D04AX01 Doxepin
                  D07875  Doxepin (INN)
             N NERVOUS SYSTEM
              N06 PSYCHOANALEPTICS
               N06A ANTIDEPRESSANTS
                N06AA Non-selective monoamine reuptake inhibitors
                 N06AA12 Doxepin
                  D07875  Doxepin (INN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01730  Non-selective monoamine reuptake inhibitor
               DG00937  Doxepin
                D07875  Doxepin
              DG01728  Tricyclic antidepressant
               DG00937  Doxepin
                D07875  Doxepin
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               DG00937  Doxepin
                D07875  Doxepin
              DG01642  CYP2C9 substrate
               DG00937  Doxepin
                D07875  Doxepin
              DG01639  CYP2C19 substrate
               DG00937  Doxepin
                D07875  Doxepin
              DG01644  CYP2D6 substrate
               DG00937  Doxepin
                D07875  Doxepin
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Histamine
                HRH1
                 D07875  Doxepin (INN)
             Transporters
              Solute carrier family
               SLC6
                SLC6A2 (NAT1)
                 D07875  Doxepin (INN)
                SLC6A4 (HTT)
                 D07875  Doxepin (INN)
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D07875
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01730  Non-selective monoamine reuptake inhibitor
               DG00937  Doxepin
              DG01728  Tricyclic antidepressant
               DG00937  Doxepin
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               DG00937  Doxepin
              DG01642  CYP2C9 substrate
               DG00937  Doxepin
              DG01639  CYP2C19 substrate
               DG00937  Doxepin
              DG01644  CYP2D6 substrate
               DG00937  Doxepin
DBLINKS     CAS: 1668-19-5
            PubChem: 96024571
            ChEBI: 4710
            PDB-CCD: 5EH
            LigandBox: D07875
            NIKKAJI: J9.508G
ATOM        21
            1   C1x C    17.0100  -21.7700
            2   C8y C    16.1700  -20.6500
            3   C8y C    16.5200  -19.3200
            4   C2y C    17.7800  -18.7600
            5   O2x O    18.4100  -21.7700
            6   C8y C    19.0400  -19.3900
            7   C8y C    19.3200  -20.7200
            8   C8x C    15.5400  -18.3400
            9   C8x C    14.1400  -18.7600
            10  C8x C    13.8600  -20.0900
            11  C8x C    14.8400  -21.0700
            12  C8x C    20.6500  -21.1400
            13  C8x C    21.7000  -20.2300
            14  C8x C    21.4200  -18.9000
            15  C8x C    20.0900  -18.4100
            16  C2b C    17.7800  -17.2900
            17  C1b C    16.5676  -16.5900
            18  C1b C    15.3721  -17.2804
            19  N1c N    14.1847  -16.5949
            20  C1a C    12.9935  -17.2829
            21  C1a C    14.1845  -15.1902
BOND        23
            1     3   4 1
            2     1   5 1
            3     4   6 1
            4     2   3 1
            5     5   7 1
            6     1   2 1
            7     6   7 1
            8     3   8 2
            9     8   9 1
            10    9  10 2
            11   10  11 1
            12    2  11 2
            13    7  12 2
            14   12  13 1
            15   13  14 2
            16   14  15 1
            17    6  15 2
            18    4  16 2
            19   16  17 1
            20   17  18 1
            21   18  19 1
            22   19  20 1
            23   19  21 1
///
